Blume Capital Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7K Hold
34
﹤0.01% 266
2026
Q1
$12.7K Sell
34
-32
-48% -$13.7K ﹤0.01% 265
2025
Q4
$28K Buy
66
+1
+2% +$435 0.01% 214
2025
Q3
$29.3K Hold
65
0.01% 223
2025
Q2
$31.8K Hold
65
0.01% 212
2025
Q1
$40.2K Hold
65
0.01% 194
2024
Q4
$34.6K Hold
65
0.01% 204
2024
Q3
$39.2K Sell
65
-5
-7% -$2.83K 0.01% 202
2024
Q2
$38K Hold
70
0.01% 193
2024
Q1
$45K Sell
70
-10
-13% -$6.08K 0.01% 187
2023
Q4
$46.9K Hold
80
0.01% 182
2023
Q3
$41.6K Hold
80
0.01% 182
2023
Q2
$43.3K Buy
+80
New +$43.7K 0.01% 175

Other funds holding CHE

Blume Capital Management's CHE Position: Q2 2026 in Review

Blume Capital Management held its Chemed (CHE) position steady in Q2 2026 at 34 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #266.

Blume Capital Management first reported a position in CHE in Q2 2023 and has held it in 13 quarters since. The position peaked at $46.9K in Q4 2023. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Blume Capital Management held 34 shares of Chemed worth $15.7K as of Q2 2026.
  • Blume Capital Management left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of Blume Capital Management's portfolio in Q2 2026, its #266 holding.
  • Blume Capital Management first reported a position in Chemed in Q2 2023 and has held it in 13 quarters since.
  • Blume Capital Management's Chemed position peaked at $46.9K in Q4 2023.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.